Suppr超能文献

标准早餐对环丙沙星药物吸收及多剂量药代动力学的影响。

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

作者信息

Ledergerber B, Bettex J D, Joos B, Flepp M, Lüthy R

出版信息

Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.

Abstract

Ciprofloxacin was administered to 10 volunteers, who received seven oral doses of 250 mg each at 12-h intervals. Volunteers alternately fasted (F) or received a standard breakfast (B) before the morning dose. Pharmacokinetic parameters were derived from high-pressure liquid chromatography data from samples taken after the first and seventh doses and were analyzed in addition for differences caused by food intake. A significant (P less than 0.05) influence of the standard breakfast on the time to the peak was observed. Peak levels (+/- standard deviation) after the first and seventh doses averaged F (fasting): 1.35 +/- 0.17, B (breakfast): 1.02 +/- 0.28 micrograms/ml, and F: 1.41 +/- 0.32, B: 1.17 +/- 0.5 micrograms/ml, respectively. Mean trough concentrations after the first and seventh doses were F: 0.10 +/- 0.03, B: 0.14 +/- 0.03 micrograms/ml, and F: 0.16 +/- 0.05, B: 0.14 +/- 0.04 microgram/ml, respectively. As with the peak, trough concentrations were not affected significantly by food intake or by accumulation over the study period. Breakfast equally did not affect the terminal half-lives, which averaged F: 3.97 +/- 0.67, B: 4.35 +/- 0.88 h after the first dose and F: 4.64 +/- 0.91, B: 3.72 +/- 0.84 h after the seventh dose. Twelve-hour urinary recovery measured by high-pressure liquid chromatography averaged F: 31, B: 30% for the first dose and, in spite of a possible carry-over from the sixth dose, decreased to F: 25, B: 28% after the seventh dosing interval. When measured by bioassay, an increase of urinary recovery between the first dose (F: 38, B: 38%) and the seventh dose (F: 45, B: 45%) was observed. These differences suggest induction of drug metabolism with repeated doses. Ciprofloxacin was well tolerated by the volunteers.

摘要

给10名志愿者服用环丙沙星,他们每隔12小时口服7次,每次250毫克。志愿者在早晨服药前交替禁食(F)或食用标准早餐(B)。药代动力学参数来自首次和第七次给药后采集样本的高压液相色谱数据,并分析了食物摄入造成的差异。观察到标准早餐对达峰时间有显著影响(P小于0.05)。首次和第七次给药后的峰浓度(±标准差)平均为:禁食(F)时,1.35±0.17;早餐(B)时,1.02±0.28微克/毫升,以及首次给药后禁食时1.41±0.32,早餐时1.17±0.5微克/毫升。首次和第七次给药后的平均谷浓度分别为:禁食时0.10±0.03,早餐时0.14±0.03微克/毫升,以及首次给药后禁食时0.16±0.05,早餐时0.14±0.04微克/毫升。与峰浓度一样,谷浓度不受食物摄入或研究期间蓄积的显著影响。早餐同样不影响终末半衰期,首次给药后平均禁食时为:3.97±0.67小时,早餐时为4.35±0.88小时;第七次给药后禁食时为4.64±0.91小时,早餐时为3.72±0.84小时。通过高压液相色谱法测得的12小时尿回收率,首次给药时平均禁食为31%,早餐为30%,尽管可能存在第六次给药的残留影响,但在第七次给药间隔后降至禁食时25%,早餐时28%。通过生物测定法测量时,观察到首次给药(禁食时38%,早餐时38%)和第七次给药(禁食时45%,早餐时45%)之间尿回收率有所增加。这些差异表明重复给药会诱导药物代谢。志愿者对环丙沙星耐受性良好。

相似文献

1
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.
2
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
Eur J Clin Microbiol. 1986 Apr;5(2):179-86. doi: 10.1007/BF02013983.
3
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
Antimicrob Agents Chemother. 1984 Nov;26(5):741-4. doi: 10.1128/AAC.26.5.741.
4
Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.
J Antimicrob Chemother. 1986 May;17(5):629-35. doi: 10.1093/jac/17.5.629.
5
Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.
J Clin Pharmacol. 1986 Mar;26(3):222-6. doi: 10.1002/j.1552-4604.1986.tb02938.x.
6
Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
Eur J Clin Microbiol. 1986 Apr;5(2):187-92. doi: 10.1007/BF02013984.
7
Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
Antimicrob Agents Chemother. 1986 Jan;29(1):62-6. doi: 10.1128/AAC.29.1.62.
8
Multiple-dose ciprofloxacin dose ranging and kinetics.
Clin Pharmacol Ther. 1985 Jun;37(6):633-7. doi: 10.1038/clpt.1985.102.
9
Pharmacokinetics and tissue penetration of ciprofloxacin.
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
10
Single and multiple dose pharmacokinetics of ciprofloxacin.
Eur J Clin Microbiol. 1986 Apr;5(2):193-6. doi: 10.1007/BF02013985.

引用本文的文献

1
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.
Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28.
3
Genome-wide association study to identify SNPs and candidate genes associated with body size traits in donkeys.
Front Genet. 2023 Feb 28;14:1112377. doi: 10.3389/fgene.2023.1112377. eCollection 2023.
4
5
Building in-house PBPK modelling tools for oral drug administration from literature information.
ADMET DMPK. 2019 Feb 23;7(1):4-21. doi: 10.5599/admet.638. eCollection 2019.
6
Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects.
Clin Pharmacol Drug Dev. 2021 Jan;10(1):57-67. doi: 10.1002/cpdd.848. Epub 2020 Jul 20.
7
8
Food-drug interactions.
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
9
Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.
Clin Pharmacokinet. 2001;40 Suppl 1:19-25. doi: 10.2165/00003088-200140001-00003.
10
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
Clin Pharmacokinet. 2001;40(3):169-87. doi: 10.2165/00003088-200140030-00003.

本文引用的文献

1
Pharmacokinetics and tissue penetration of ciprofloxacin.
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
2
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Antimicrob Agents Chemother. 1984 May;25(5):633-7. doi: 10.1128/AAC.25.5.633.
3
In vitro activity of ciprofloxacin (Bay o 9867).
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
4
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
5
7
CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.
J Pharm Sci. 1976 Jul;65(7):1006-10. doi: 10.1002/jps.2600650713.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验